UFP Technologies Inc. (UFPT)
UFPT trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/914156/000162828026012816/0001628280-26-012816-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | UFPT on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 1993 |
| SEC CIK | 0000914156 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $602.8M |
| Net income | $68.3M |
| Operating income | $92.3M |
| Net margin | 11.3% |
| Operating margin | 15.3% |
| Revenue growth | +19.5% |
| Cash | $20.3M |
| Total assets | $655.1M |
| P/E (computed) | 33.9× |
| P/S (computed) | 3.8× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-06 |
| Cash and burn | $20.6M cash; operating cash flow $18.5M a quarter. | Report 2026-09-30 |
| Shares outstanding | 7,746,986 (2026-10-25); 7,712,444 a year earlier; 7,638,812 three years earlier. | Cover page 2026-10-25 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Grant Thornton LLP, Boston, Massachusetts, United States | PCAOB Form AP 2026-03-02 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $14.0M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $172.4M | $20.6M | $38.5M | $20.6M | $96.0M | $649.5M | 10-Q 2026-11-06 |
| Q2 2026 2026-06-30 | $174.0M | $20.9M | $15.6M | $9.0M | $117.3M | $631.6M | 10-Q 2026-08-06 |
| Q1 2026 2026-03-31 | $154.2M | $17.5M | $3.2M | $20.0M | $137.6M | $608.9M | 10-Q 2026-05-08 |
| Q4 2025 2025-12-31 | $148.9M | $17.6M | $16.8M | $20.3M | $135.5M | $602.8M | 10-K 2026-02-27 |
| Q3 2025 2025-09-30 | $154.6M | $16.4M | $35.9M | $18.2M | $146.1M | $598.0M | 10-Q 2026-11-06 |
| Q2 2025 2025-06-30 | $151.2M | $17.2M | $25.3M | $14.9M | $163.6M | $588.6M | 10-Q 2026-08-06 |
| Q1 2025 2025-03-31 | $148.1M | $17.2M | $13.8M | $14.0M | $163.6M | $547.6M | 10-Q 2026-05-08 |
| Q4 2024 2024-12-31 | $144.1M | $16.4M | $24.4M | $13.4M | $189.4M | $504.4M | 10-K 2026-02-27 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest annual report | 10-K | 2026-02-27 |
| Latest quarterly / interim | 10-Q | 2026-11-06 |
| Latest current report | 8-K | 2026-11-03 |
| Latest proxy | DEF 14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +0.5% |
| 1 month | +3.7% |
| 3 months | -4.6% |
| Year to date | +37.4% |
| 1 year | +30.2% |
| From 52-week high | -8.9% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ATRC | AtriCure Inc. | $55.31 | -2.69% | $2.8B |
| VVVV | vVARDIS Holding AG | $16.00 | -3.03% | $2.9B |
| XRAY | DENTSPLY SIRONA Inc. | $8.95 | -2.35% | $1.8B |
| LMAT | LeMaitre Vascular Inc. | $77.01 | -1.63% | $1.8B |
| IRTC | iRhythm Holdings Inc. | $90.83 | -1.18% | $3.1B |
| INSP | Inspire Medical Systems Inc. | $59.12 | -3.24% | $1.7B |
| KMTS | Kestra Medical Technologies Ltd. | $27.97 | -2.34% | $1.7B |
| PLSE | Pulse Biosciences Inc Common Stock (DE) | $46.36 | -8.09% | $3.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier